NCT01552434 2025-10-14
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
M.D. Anderson Cancer Center
University of Cincinnati
University of Cincinnati
University of Cincinnati
University of Cincinnati
University of Pennsylvania
Brigham and Women's Hospital
Cardiff University
Children's Hospital Medical Center, Cincinnati